These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12113989)

  • 1. Simultaneous determination of indinavir, ritonavir and lopinavir (ABT 378) in human plasma by high-performance liquid chromatography.
    Ray J; Pang E; Carey D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 775(2):225-30. PubMed ID: 12113989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC.
    Kuschak D; Mauss S; Schmutz G; Gantke B
    Clin Lab; 2001; 47(9-10):471-7. PubMed ID: 11596909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
    Verbesselt R; Van Wijngaerden E; de Hoon J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
    Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of lopinavir and ritonavir in human plasma by high performance liquid chromatography coupled with UV detection.
    Kou H; Ye M; Fu Q; Han Y; Du X; Xie J; Zhu Z; Li T
    Sci China Life Sci; 2012 Apr; 55(4):321-7. PubMed ID: 22566088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
    Bouley M; Briere C; Padoin C; Petitjean O; Tod M
    Ther Drug Monit; 2001 Feb; 23(1):56-60. PubMed ID: 11206045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy.
    Langmann P; Klinker H; Schirmer D; Zilly M; Bienert A; Richter E
    J Chromatogr B Biomed Sci Appl; 1999 Nov; 735(1):41-50. PubMed ID: 10630889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantitation of HIV-protease inhibitors ritonavir, lopinavir and indinavir in human plasma by UPLC-ESI-MS-MS.
    Das Mishra T; Kurani H; Singhal P; Shrivastav PS
    J Chromatogr Sci; 2012 Aug; 50(7):625-35. PubMed ID: 22562821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC-ESI-MS/MS for bioequivalence study in Indian subjects.
    Yadav M; Rao R; Kurani H; Singhal P; Goswami S; Shrivastav PS
    J Pharm Biomed Anal; 2009 May; 49(4):1115-22. PubMed ID: 19282124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
    Weller DR; Brundage RC; Balfour HH; Vezina HE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Choi SO; Rezk NL; Kashuba AD
    J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
    Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
    Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
    Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
    Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and application of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid-liquid extraction.
    Wang PG; Wei JS; Kim G; Chang M; El-Shourbagy T
    J Chromatogr A; 2006 Oct; 1130(2):302-7. PubMed ID: 16919649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
    Keil K; Frerichs VA; DiFrancesco R; Morse G
    Ther Drug Monit; 2003 Jun; 25(3):340-6. PubMed ID: 12766563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
    Droste JA; Verweij-Van Wissen CP; Burger DM
    Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.